159635-50-4

Basic information

• Product Name: N-Boc-N,N-bis(2-bromoethyl)amine
• Synonyms: N-Boc-N,N-bis(2-bromoethyl)amine;N-Boc-N,N-bis(2-broMoethy...;CarbaMic acid,bis(2-broMoethyl)-, 1,1-diMethylethyl ester (9CI);tert-Butyl bis(2-broMoethyl)carbaMate;tert-butyl N,N-bis(2-bromoethyl)carbamate
• CAS NO: 159635-50-4
• Molecular Formula: C₉H₁₇Br₂NO₂
• Molecular Weight: 331.06
• Mol File: 159635-50-4.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 317.7 °C at 760 mmHg
• Flash Point: 146 °C
• Appearance: /
• Density: 1.545 g/cm³
• Vapor Pressure: 0.000378mmHg at 25°C
• Refractive Index: 1.515
• PKA: -1.80±0.70(Predicted)
• CAS DataBase Reference: N-Boc-N,N-bis(2-bromoethyl)amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-Boc-N,N-bis(2-bromoethyl)amine(159635-50-4)
• EPA Substance Registry System: N-Boc-N,N-bis(2-bromoethyl)amine(159635-50-4)

Safety Data

• Hazardous Substances Data: 159635-50-4(Hazardous Substances Data)

Usage

General Description

N-Boc-N,N-bis(2-bromoethyl)amine is a chemical compound often applied in the field of synthetic chemistry as a reagent to aid in the creation of other diverse and complex molecules. An organic compound, it usually appears as a clear to slightly yellow liquid. Its primary features include two bromoethyl groups and a tert-butoxycarbonyl (Boc) group, which serves to protect amines in chemical reactions. This substance should be handled with care due to potential hazard concerns, including skin or eye damage. This chemical is used in many experimental and production settings, ranging from pharmaceuticals to specialty chemicals.

InChI:InChI=1/C9H17Br2NO2/c1-9(2,3)14-8(13)12(6-4-10)7-5-11/h4-7H2,1-3H3

Upstream product

• 3890-99-1 bis(2-bromoethyl)amine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 401518-11-4 [(tert-butoxycarbonyl)imino]diethane-2,1-diyl dimethanesulfonate 

Downstream Products

• 1228079-29-5 tert-butyl 1-oxo-1,3-dihydrospiro[indene-2,4’-piperidine]-1’-carboxylate 
• 362703-34-2 1-tert-butyl 4-methyl 4-cyanopiperidine-1,4-dicarboxylate 
• 362703-35-3 1-tert-butyl 4-methyl 4-(aminomethyl)piperidine-1,4-dicarboxylate 
• 362703-36-4 4-{[4-(2-methyl-quinolin-4-ylmethoxy)-benzoylamino]-methyl}-piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-methyl ester 
• 362697-41-4 1-[(1,1-dimethylethoxy)carbonyl]-N-hydroxy-4-[[[4-[(2-methyl-4-quinolinyl)methoxy]benzoyl]amino]methyl]-4-piperidinecarboxamide 
• 77278-63-8 4-phenyl-piperazine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4′-piperidine]

Cyclization of the benzoylpiperidine in lead compound 2 generated a series of novel and highly potent spiropiperidine-based stearoyl-CoA desaturase (SCD)-1 inhibitors. Among them, 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4′-piperidine] (19) demonstrated the most powerful inhibitory activity against SCD-1, not only in vitro but also in vivo (C57BL/6 J mice). With regard to the pharmacological evaluation, 19 showed powerful reduction of the desaturation index in the plasma of C57BL/6 J mice on a non-fat diet after a 7-day oral administration (q.d.) without causing notable abnormalities in the eyes or skin up to the highest dose (3 mg/kg) in our preliminary analysis.